These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 31756926)

  • 21. Identification of Individual Cancer-Specific Somatic Mutations for Neoantigen-Based Immunotherapy of Lung Cancer.
    Karasaki T; Nagayama K; Kawashima M; Hiyama N; Murayama T; Kuwano H; Nitadori J; Anraku M; Sato M; Miyai M; Hosoi A; Matsushita H; Kikugawa S; Matoba R; Ohara O; Kakimi K; Nakajima J
    J Thorac Oncol; 2016 Mar; 11(3):324-33. PubMed ID: 26752676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer Neoantigens: Challenges and Future Directions for Prediction, Prioritization, and Validation.
    Borden ES; Buetow KH; Wilson MA; Hastings KT
    Front Oncol; 2022; 12():836821. PubMed ID: 35311072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoantigen Load, Antigen Presentation Machinery, and Immune Signatures Determine Prognosis in Clear Cell Renal Cell Carcinoma.
    Matsushita H; Sato Y; Karasaki T; Nakagawa T; Kume H; Ogawa S; Homma Y; Kakimi K
    Cancer Immunol Res; 2016 May; 4(5):463-71. PubMed ID: 26980598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoantigen vaccine: An emerging immunotherapy for hepatocellular carcinoma.
    Chen P; Fang QX; Chen DB; Chen HS
    World J Gastrointest Oncol; 2021 Jul; 13(7):673-683. PubMed ID: 34322196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor Mutational Burden for Predicting Prognosis and Therapy Outcome of Hepatocellular Carcinoma.
    Gabbia D; De Martin S
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design.
    Cai W; Zhou D; Wu W; Tan WL; Wang J; Zhou C; Lou Y
    BMC Genomics; 2018 Aug; 19(1):582. PubMed ID: 30075702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of Somatic Mutations That Affect Neoantigens in Non-Small Cell Lung Cancer.
    Liang H; Xu Y; Chen M; Zhao J; Zhong W; Liu X; Gao X; Li S; Li J; Guo C; Jia H; Wang M
    Front Immunol; 2021; 12():749461. PubMed ID: 35356154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired Cytolytic Activity and Loss of Clonal Neoantigens in Elderly Patients With Lung Adenocarcinoma.
    Gong Z; Jia Q; Chen J; Diao X; Gao J; Wang X; Zhu B
    J Thorac Oncol; 2019 May; 14(5):857-866. PubMed ID: 30768970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematically Characterizing A-to-I RNA Editing Neoantigens in Cancer.
    Zhou C; Wei Z; Zhang L; Yang Z; Liu Q
    Front Oncol; 2020; 10():593989. PubMed ID: 33363023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neoantigens and Whole-Exome Sequencing].
    Karasaki T; Nakajima J; Kakimi K
    Gan To Kagaku Ryoho; 2016 Jul; 43(7):791-7. PubMed ID: 27431622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Induction of specific CD8(+) T cells against hepatocellular carcinoma-associated neoantigens].
    Wang YM; Zhao BH; Chen K; Li ZJ; Qu CF
    Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):429-434. PubMed ID: 31216828
    [No Abstract]   [Full Text] [Related]  

  • 32. The Clinical Application of Neoantigens in Esophageal Cancer.
    Gu YM; Zhuo Y; Chen LQ; Yuan Y
    Front Oncol; 2021; 11():703517. PubMed ID: 34386424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of mass spectrometry-based MHC immunopeptidome profiling in neoantigen identification for tumor immunotherapy.
    Zhang X; Qi Y; Zhang Q; Liu W
    Biomed Pharmacother; 2019 Dec; 120():109542. PubMed ID: 31629254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated neoantigen levels in tumors with somatic mutations in the HLA-A, HLA-B, HLA-C and B2M genes.
    Castro A; Ozturk K; Pyke RM; Xian S; Zanetti M; Carter H
    BMC Med Genomics; 2019 Jul; 12(Suppl 6):107. PubMed ID: 31345234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Comprehensive Survey of Genomic Mutations in Breast Cancer Reveals Recurrent Neoantigens as Potential Therapeutic Targets.
    Zhou S; Liu S; Zhao L; Sun HX
    Front Oncol; 2022; 12():786438. PubMed ID: 35387130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoantigen vaccine: an emerging tumor immunotherapy.
    Peng M; Mo Y; Wang Y; Wu P; Zhang Y; Xiong F; Guo C; Wu X; Li Y; Li X; Li G; Xiong W; Zeng Z
    Mol Cancer; 2019 Aug; 18(1):128. PubMed ID: 31443694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An immunogenic personal neoantigen vaccine for patients with melanoma.
    Ott PA; Hu Z; Keskin DB; Shukla SA; Sun J; Bozym DJ; Zhang W; Luoma A; Giobbie-Hurder A; Peter L; Chen C; Olive O; Carter TA; Li S; Lieb DJ; Eisenhaure T; Gjini E; Stevens J; Lane WJ; Javeri I; Nellaiappan K; Salazar AM; Daley H; Seaman M; Buchbinder EI; Yoon CH; Harden M; Lennon N; Gabriel S; Rodig SJ; Barouch DH; Aster JC; Getz G; Wucherpfennig K; Neuberg D; Ritz J; Lander ES; Fritsch EF; Hacohen N; Wu CJ
    Nature; 2017 Jul; 547(7662):217-221. PubMed ID: 28678778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population-level distribution and putative immunogenicity of cancer neoepitopes.
    Wood MA; Paralkar M; Paralkar MP; Nguyen A; Struck AJ; Ellrott K; Margolin A; Nellore A; Thompson RF
    BMC Cancer; 2018 Apr; 18(1):414. PubMed ID: 29653567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non-Small Cell Lung Cancer.
    Jia Q; Chiu L; Wu S; Bai J; Peng L; Zheng L; Zang R; Li X; Yuan B; Gao Y; Wu D; Li X; Wu L; Sun J; He J; Robinson BWS; Zhu B
    Adv Sci (Weinh); 2020 May; 7(9):1903410. PubMed ID: 32382482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 'Hotspots' of Antigen Presentation Revealed by Human Leukocyte Antigen Ligandomics for Neoantigen Prioritization.
    Müller M; Gfeller D; Coukos G; Bassani-Sternberg M
    Front Immunol; 2017; 8():1367. PubMed ID: 29104575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.